These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 24175168)

  • 1. Neuroplasticity and major depression, the role of modern antidepressant drugs.
    Serafini G
    World J Psychiatry; 2012 Jun; 2(3):49-57. PubMed ID: 24175168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How antidepressant drugs act: A primer on neuroplasticity as the eventual mediator of antidepressant efficacy.
    Andrade C; Rao NS
    Indian J Psychiatry; 2010 Oct; 52(4):378-86. PubMed ID: 21267376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hippocampal neurogenesis, neurotrophic factors and depression: possible therapeutic targets?
    Serafini G; Hayley S; Pompili M; Dwivedi Y; Brahmachari G; Girardi P; Amore M
    CNS Neurol Disord Drug Targets; 2014; 13(10):1708-21. PubMed ID: 25470403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurobiological and clinical effects of the antidepressant tianeptine.
    Kasper S; McEwen BS
    CNS Drugs; 2008; 22(1):15-26. PubMed ID: 18072812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Depression and treatment. Apoptosis, neuroplasticity and antidepressants].
    Arantes-Gonçalves F; Coelho R
    Acta Med Port; 2006; 19(1):9-20. PubMed ID: 16987439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is neurogenesis relevant in depression and in the mechanism of antidepressant drug action? A critical review.
    Tang SW; Helmeste D; Leonard B
    World J Biol Psychiatry; 2012 Sep; 13(6):402-12. PubMed ID: 22175526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remodeling of axo-spinous synapses in the pathophysiology and treatment of depression.
    Licznerski P; Duman RS
    Neuroscience; 2013 Oct; 251():33-50. PubMed ID: 23036622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroplasticity-related mechanisms underlying the antidepressant-like effects of traditional herbal medicines.
    Hirshler Y; Doron R
    Eur Neuropsychopharmacol; 2017 Oct; 27(10):945-958. PubMed ID: 28807619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The monoaminergic tripartite synapse: a putative target for currently available antidepressant drugs.
    Quesseveur G; Gardier AM; Guiard BP
    Curr Drug Targets; 2013 Oct; 14(11):1277-94. PubMed ID: 24020973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Depression and neuroplasticity: implication of serotoninergic systems].
    Daszuta A; Ban M; Soumier A; Hery M; Mocaer E
    Therapie; 2005; 60(5):461-8. PubMed ID: 16433011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neural basis of major depressive disorder: Beyond monoamine hypothesis.
    Boku S; Nakagawa S; Toda H; Hishimoto A
    Psychiatry Clin Neurosci; 2018 Jan; 72(1):3-12. PubMed ID: 28926161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral effects of toll-like receptor-4 antagonist 'eritoran' in an experimental model of depression: role of prefrontal and hippocampal neurogenesis and γ-aminobutyric acid/glutamate balance.
    Aboul-Fotouh S; Habib M; Asaad T; Kassim SK; Ghanem MH
    Behav Pharmacol; 2018 Aug; 29(5):413-425. PubMed ID: 29561292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroplasticity and depression: Rewiring the brain's networks through pharmacological therapy (Review).
    Rădulescu I; Drăgoi AM; Trifu SC; Cristea MB
    Exp Ther Med; 2021 Oct; 22(4):1131. PubMed ID: 34504581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel insights into depression and antidepressants: a synergy between synaptogenesis and neurogenesis?
    Bambico FR; Belzung C
    Curr Top Behav Neurosci; 2013; 15():243-91. PubMed ID: 23271325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of neurogenesis and gliogenesis by stress and antidepressant treatment.
    Banasr M; Duman RS
    CNS Neurol Disord Drug Targets; 2007 Oct; 6(5):311-20. PubMed ID: 18045159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic Ketamine Treatment Promotes Resilience to Chronic Stress and Accelerates Recovery: Correlation with Changes in Synaptic Plasticity in the CA3 Subregion of the Hippocampus.
    Krzystyniak A; Baczynska E; Magnowska M; Antoniuk S; Roszkowska M; Zareba-Koziol M; Das N; Basu S; Pikula M; Wlodarczyk J
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30965559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The modulation of adult neuroplasticity is involved in the mood-improving actions of atypical antipsychotics in an animal model of depression.
    Morais M; Patrício P; Mateus-Pinheiro A; Alves ND; Machado-Santos AR; Correia JS; Pereira J; Pinto L; Sousa N; Bessa JM
    Transl Psychiatry; 2017 Jun; 7(6):e1146. PubMed ID: 28585931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurogenesis and Neuroplasticity in Major Depression: Its Therapeutic Implication.
    Bourin M
    Adv Exp Med Biol; 2021; 1305():157-173. PubMed ID: 33834400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stress, serotonin, and hippocampal neurogenesis in relation to depression and antidepressant effects.
    Mahar I; Bambico FR; Mechawar N; Nobrega JN
    Neurosci Biobehav Rev; 2014 Jan; 38():173-92. PubMed ID: 24300695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult hippocampal neurogenesis: an actor in the antidepressant-like action.
    Mendez-David I; Hen R; Gardier AM; David DJ
    Ann Pharm Fr; 2013 May; 71(3):143-9. PubMed ID: 23622692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.